Articles tagged with: International Myeloma Foundation
NewsFlash »
The Bloom: Fashion Show Extravaganza ― Fashion designer Christine Phillips will donate the proceeds of her annual fashion show to the International Myeloma Foundation (IMF). Hosted by NBC 10’s Monique Braxton, the fashion show will be held on January 31, from 6 p.m. to 8 p.m. at the National Constitution Center in Philadelphia. For further information or to register, visit the Christine Phillips Web site.
Fifth Annual Charity Art Show & Wine Tasting ― The event is held in memory of Hannah Pites, a six-year-old multiple myeloma patient who passed away from the disease in 2005. In its first four years, the event raised over $20,000 for the Leukemia & Lymphoma Society (LLS). This year’s event will be held on January 31, from 5 p.m. to 11 p.m. at McMenamins Old St. Francis School in Bend, OR. Those who are unable to attend can donate art or wine. For more information, visit the LLS Web site.
Kaiser Permanente San Francisco Half Marathon ― The race will begin at 8 a.m. on February 1, on John F. Kennedy Drive in San Francisco. The half marathon will wind through the Golden Gate Park and along Ocean Beach. The event’s official sponsors are the Koret Family House, The Harbor Light Center for Alcoholism and Drug Abuse, and Support for Families of Children with Disabilities. Participants may make a personal donation to the Leukemia & Lymphoma Society, who is separately sponsoring the event. For more information, visit the Kaiser Permanente San Francisco Half Marathon Web site.
Australian Country Stars Walk For Blood Cancer Research ― On January 26, musicians Gina Jeffreys, Kasey Chambers, and Troy Cassar-Daley, along with over 200 people, walked down the main street of Tamworth, Australia, in support of the Australian Leukaemia Foundation. Three years ago, Gina Jeffreys organized the first walk after receiving a letter from a six-year-old leukemia patient. The Australian Leukaemia Foundation supports research for leukemia, lymphoma, and myeloma. For more information, visit the Look to the Stars Web Site.
News»
Steroids such as dexamethasone and prednisone are frequently used to treat myeloma patients. They reduce swelling and inflammation and have been shown to kill myeloma cells. However, steroids can also cause many serious side effects.
Both dexamethasone and prednisone can be prescribed alone or in combination with novel anti-myeloma drugs, which include thalidomide (Thalomid), Revlimid (lenalidomide), and Velcade (bortezomib). Prednisone is also used to enhance the response rate of melphalan therapy in myeloma patients.
Side effects caused by these steroids include, but are not limited to, …
News»
At this year's American Society of Hematology (ASH) meeting, the International Myeloma Foundation (IMF) will report new progress on multiple myeloma research and will introduce five long-term patients who have benefited from novel treatments. Although multiple myeloma is an incurable cancer, new treatments used in combination and in sequence have dramatically improved the quality of life for many patients.
The five patients represented by the IMF at the meeting will be: Hardy Jones, a five-year multiple myeloma survivor who now studies the link between toxins in the marine environment and multiple myeloma; …
News»
The International Myeloma Foundation (IMF) held its second annual Comedy Celebration benefiting The Peter Boyle Memorial Fund on Saturday in Los Angeles, California.
Peter Boyle was an Emmy Award-winning actor and was most recently well-known as the father, Frank Barone, on the CBS show Everybody Loves Raymond. Fellow cast members Ray Romano, Doris Roberts, and Patricia Heaton were among the guests at this year's benefit.
The Peter Boyle Memorial Fund was started by his family in 2006 after his death from multiple myeloma and heart disease. Its main …
News»
On November 18, the International Myeloma Foundation (IMF) announced a global research partnership that will study cancers affecting the immune system, including multiple myeloma. The collaboration is between IMF Chairman Brian G.M. Durie, M.D., of the United States; Luc Montagnier, M.D., co-recipient of the 2008 Nobel Prize in medicine, of France; and Howard Urnovitz, Ph.D., CEO of Chronix Biomedical, of Germany.
Dr. Montagnier’s pioneering research, which discovered the virus that causes AIDS, will lay the groundwork for the study, as both AIDS and multiple myeloma …
NewsFlash »
Postgraduate Institute For Medicine Sponsors Conference On New Multiple Myeloma Treatments - In conjunction with the International Myeloma Foundation (IMF), the Postgraduate Institute for Medicine is sponsoring a December 5 symposium entitled, "Multiple Myeloma: Finding Your Way Through the Treatment Maze--Selecting the Best Treatment in the Era of Novel Agents." Hosted from 6:00 - 9:00 p.m. in San Francisco's Moscone Center, the program will provide an overview of the most recent clinical trials' findings, including results on the newest therapeutic approaches for treating both initial and recurring multiple myeloma. For more information on the symposium, including how to register, please visit the IMF Web site.
International Myeloma Foundation Hosts 4th Annual Southwest Symposium - The International Myeloma Foundation (IMF) is hosting its 4th Annual Southwest Symposium at Arizona State University, Sandra Day O'Connor College of Law, on November 22. The program, specifically designed for patients and their families, will include presentations on emerging treatments and front line therapies, managing side effects, and understanding scientific literature, among other topics. Individuals interested in attending the seminar may find more information by visiting the IMF Web site.
News»
International Myeloma Foundation (IMF) president and cofounder, Susie Novis, called for all patients to have access to the newest pharmaceuticals in the treatment of multiple myeloma.
"We support efforts that put patients first, support healthcare advances, and work for better outcomes until there is a cure," explained Novis. "While we understand that cost of treatment is always a consideration, we believe society pays a higher price when the most vulnerable people among us - patients with a deadly disease - are denied access to transformational therapeutics that can prolong …